Multicellular living organisms and unmodified parts thereof and – Nonhuman animal – The nonhuman animal is a model for human disease
Reexamination Certificate
1999-01-21
2001-03-13
LeGuyader, John L. (Department: 1633)
Multicellular living organisms and unmodified parts thereof and
Nonhuman animal
The nonhuman animal is a model for human disease
C800S003000, C800S018000, C800S024000, C435S320100, C536S024100
Reexamination Certificate
active
06201166
ABSTRACT:
TECHNICAL FIELD OF THE INVENTION
The present invention relates to a hepatitis C animal model, which is useful for clarification of an onset mechanism of hepatitis C, development of means for treating the disease, and so on.
BACKGROUND OF THE INVENTION
Until now, many attempts have been made to produce an onset model of hepatitis by introducing a hepatitis C virus (hereinafter, referred to as “HCV”) gene into a small animal such as mouse and expressing the introduced gene (C. Pasquinelli et al., Abstract book of 2nd international meeting on hepatitis C virus and related viruses (Jul. 31-Aug. 5, 1994 San Diego, USA); C. Pasquinelli et al., Abstract book of 3rd international meeting on hepatitis C virus and related viruses (Aug. 28-Sep. 3, 1995 Gold coast, Australia); Kazuhiko Koike et al., J. General Virology 76 pp.3031-3038 1995; and T.Kato, Arch Virol 141 pp.951-958 1996). However, unlike many other genes, the HCV gene was difficult to be integrated into a murine individual, and even if it was successfully integrated into the animal, production of an HCV protein did not take place in most cases. Furthermore, even in the extremely rare case where an HCV protein was produced in the animal, use as a hepatitis model was impossible since the protein was produced from the fetal period, thereby causing an immunological tolerance which resulted in no animal exhibiting typical hepatitis symptoms after birth.
PROBLEM TO BE SOLVED BY THE INVENTION
In clarifying an onset mechanism of a human disease and developing means for treating the disease, an animal model presenting pathological conditions very similar to those of the disease plays an important role.
However, as described above, a hepatitis C animal model has not yet been produced, and this has been one of the obstacles in clarifying the onset mechanism of hepatitis C.
The present invention arises from such a technical background. An object of the present invention is to provide a novel animal model that exhibits the pathological conditions analogous to human hepatitis C.
REFERENCES:
patent: 5650298 (1997-07-01), Bujard et al.
patent: 5849987 (1998-12-01), Reisner
patent: 5858328 (1999-01-01), Reisner
Yamamota, M., et al,In Vivo Transfection of Hepatitis C Virus Complementary DNA Into Rodent Liver by Asialoglycoprotein Receptor Mediated Gene Delivery, Hepatology, vol. 22 (3), pp. 847-855 (1995).
Takehara, T., et al.,Expression of the Full-Coding Sequence of the Hepatitis C Virus Genome in Adult Rat Liver Using Cationic Liposome-Mediated In Vivo Gene Transfer, Hepatology, vol. 20, p. 232A (1994).
Koike, K., et al.,Expression of Hepatitis C Virus Envelope Proteins in Transgenic Mice, J. Gen. Virol., vol. 76, pp. 3031-3038 (1995).
Kato, T., et al.,Inactivation of Hepatitis C Virus cDNA Transgene by Hypermethylation in Transgenic Mice, Arch.Virol., vol. 141, pp. 951-958 (1996).
Sternberg, N., et al.,Bacteriophage P1 Site-specific Recombination, J. Mol. Biol., vol. 150, pp. 487-507 (1981).
White D and Fenner F Medical Virology 447, 1994.
Hammer R et al. Journal of Animal Science 63:269-278, 1986.
Ebert K et al. Molecular Endocrinology 2:277-283, 1988.
Mullins L and Mullins J Journal of Clinical Investigations (98)11:S37-S40, 1996.
Wall RJ Theriogenology 45:57-68, 1996.
Strojek R and Wagner T Genetic Engineering: Principles and methods, vol. 10, pp. 221-246, 1988.
Kappel CA et al. Current Opinion in Biotechnology 3:548-553, 1992.
Houdebine LM Journal of Biotechnology 34:269-287, 1994.
Koike K et al. Journal of General Virology 76:3031-3038, 1995.
Orban P et al. Proceedings of the National Aademy of Science 89:6861-6865, 1992.
Kim C-M et al. Nature 351: 317-320, 1991.
Kuhn r et al. Science 269: 1427-1429, 1995.
Kato T et al. Archives of Virology 141: 951-958, 1996.
Miller and Vile The FASEB Journal 9:190-199, 1995.
Hodgson Exp. Opin. Ther. Patents 5(5):459-468, 1995.
Kohara Michinori
Saito Izumu
Taya Choji
Wakita Takaji
Yonekawa Hiromichi
Davidson Davidson & Kappel LLC
LeGuyader John L.
Tokyo Metropolitan Institute of Medical Science
LandOfFree
Transgenic mouse hepatitis C virus model comprising a... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Transgenic mouse hepatitis C virus model comprising a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transgenic mouse hepatitis C virus model comprising a... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2459422